Chongkundang Holdings

001630 · KOSPI · Health Care · SMALL CAP

Revenue up 0.1% in FY2025.

Chongkundang Holdings reported consolidated results for FY2025: revenue of US$659M (+0.1% year on year), operating profit of US$40M (+64.2% year on year) and net income of US$37.3M (+34.8% year on year).

Earnings(Change of 30% or more in revenue or profit/loss structure (15% for large companies))· FILED 2026-02-11· RCEPT 20260211801328

US$659MRevenue
+0.1%Revenue vs a year earlier
US$40MOperating profit

Converted at 1 USD ≈ ₩1,455.33 (filing-date rate, 2026-02-11 close)

What happened

Chongkundang Holdings reported consolidated results for FY2025: revenue of US$659M (+0.1% year on year), operating profit of US$40M (+64.2% year on year) and net income of US$37.3M (+34.8% year on year).

Korean rules require this filing when revenue or profit moves 30% or more from the prior year (15% for large companies). The figures are the company's own and may not be audited yet.

RevenueUS$659M
Revenue vs a year earlier+0.1%
Operating profitUS$40M
Net incomeUS$37.3M
PeriodFY2025 (consolidated)
Filed2026-02-11, Change of 30% or more in revenue or profit/loss structure (15% for large companies)
SourceDART rcept 20260211801328 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-02-11 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.